MacroGenics
MGNX
#8189
Rank
A$0.40 B
Marketcap
A$6.32
Share price
6.84%
Change (1 day)
174.99%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.40 Billion

As of May 2026 MacroGenics has a market cap of A$0.40 Billion. This makes MacroGenics the world's 8189th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.40 B164.28%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On May 25th, 2026 the market cap of MacroGenics was reported to be:

A$0.40 Billion
by Nasdaq info icon info icon
A$0.40 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$206.01 B 51,165.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.325 T 329,726.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$255.56 B 63,497.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$232.81 B 57,834.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$421.93 B 104,897.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$169.45 B 42,068.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.17 B 191.22%๐Ÿ‡บ๐Ÿ‡ธ USA